Access a multi-indication oncology dataset based on EMR data that offers comprehensive insights into the full range of oncological diseases, revealing unmet epidemiological needs and providing a holistic understanding of patient journeys at scale.
Vista allows life sciences to holistically track the journeys of real oncology patients across the disease spectrum. The inclusion of non-oncological data enables further identification of epidemiological trends and guidance of research decisions.
Vista uses structured EMR data and machine learning to standardize patient data across disease states and treatment protocols for easy comparative analysis.
Vista is continuously being improved and enriched with data and clinical logic through collaboration with biopharma partners.
Real-World Insights and Support is an optional add-on that pairs perfectly with your Vista data. Our team of clinical experts, researchers, and statisticians will come alongside your teams to help them use the data to design studies, run analyses, and construct regulatory submission packages.
Explore our collection of clinical research, recent press, podcasts, and more.
Four Ways Pharmaceutical Companies Are De-Risking R&D with Real-World Data Pharmaceutical research and development is inherently complex and high-risk. Sponsors...
Cancer affects everyone, including adolescents and young adults who are at increasing risk of developing certain types of disease. It’s...
Cancer is a disease that respects no borders: it affects everyone around the world, no matter where they live. The...
Discover the power of real-world cancer data to help you understand patient journeys across the oncology spectrum and inform research directions.
